Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05017701 · ClinicalTrials.gov registry record
Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty
A clinical trial, sponsored by Masimo Corporation.
- Terminated
- Registry status
- 5
- Enrollment target
NCT05017701: Clinical Trial study, sponsored by Masimo Corporation.
NCT05017701 is a clinical trial that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05017701 was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The aim of this research study is to gather data regarding the feasibility of the Bridge system for the management of pain following total hip arthroplasty (THA).
Primary Outcome
The sample size is well below the threshold needed to reliably assess outcomes and perform statistical comparisons. As a result, we have provided the raw data for comparison of opioid consumption between the two groups.
Interventions
- DEVICE Sham device
- DEVICE Bridge device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-04-26 |
| Est. Completion | 2023-05-24 |
Why NCT05017701 stopped before completion
NCT05017701 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Sham device is the first listed.
NCT05017701 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05017701 about?
NCT05017701 is a clinical study titled "Feasibility of Bridge for Post-Operative Pain Management in Hip Arthroplasty". The aim of this research study is to gather data regarding the feasibility of the Bridge system for the management of pain following total hip arthroplasty (THA).
What is the current status of trial NCT05017701?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2022-04-26. Estimated completion is 2023-05-24.
What interventions are being tested in trial NCT05017701?
The interventions under investigation include: Sham device (DEVICE), Bridge device (DEVICE).
Who is sponsoring clinical trial NCT05017701?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI